Compile Data Set for Download or QSAR
Report error Found 181 Enz. Inhib. hit(s) with all data for entry = 6765
TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151765(US8987445, 201)
Affinity DataIC50: 0.600nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151774(US8987445, 210)
Affinity DataIC50: 0.800nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151677(US8987445, 104)
Affinity DataIC50: 0.900nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151797(US8987445, 233)
Affinity DataIC50: 0.900nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151745(US8987445, 181)
Affinity DataIC50: 1nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151773(US8987445, 209)
Affinity DataIC50: 1nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151748(US8987445, 184)
Affinity DataIC50: 1.10nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151749(US8987445, 185)
Affinity DataIC50: 1.20nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151655(US8987445, 61)
Affinity DataIC50: 1.30nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151758(US8987445, 194)
Affinity DataIC50: 1.30nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151766(US8987445, 202)
Affinity DataIC50: 1.40nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151767(US8987445, 203)
Affinity DataIC50: 1.5nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151786(US8987445, 222)
Affinity DataIC50: 1.60nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151799(US8987445, 235)
Affinity DataIC50: 1.60nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151753(US8987445, 189)
Affinity DataIC50: 1.70nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151785(US8987445, 221)
Affinity DataIC50: 1.70nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151636(US8987445, 23)
Affinity DataIC50: 1.80nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151630(US8987445, 10)
Affinity DataIC50: 1.90nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151678(US8987445, 106)
Affinity DataIC50: 2nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151743(US8987445, 179)
Affinity DataIC50: 2.10nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151716(US8987445, 151)
Affinity DataIC50: 2.20nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151760(US8987445, 196)
Affinity DataIC50: 2.20nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151718(US8987445, 154)
Affinity DataIC50: 2.30nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151643(US8987445, 34)
Affinity DataIC50: 2.5nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151783(US8987445, 219)
Affinity DataIC50: 2.60nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151626(US8987445, 2)
Affinity DataIC50: 2.70nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151789(US8987445, 225)
Affinity DataIC50: 2.80nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151734(US8987445, 170)
Affinity DataIC50: 2.90nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151644(US8987445, 35)
Affinity DataIC50: 3.10nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151666(US8987445, 84)
Affinity DataIC50: 3.10nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151702(US8987445, 137)
Affinity DataIC50: 3.10nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151768(US8987445, 204)
Affinity DataIC50: 3.10nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151787(US8987445, 223)
Affinity DataIC50: 3.5nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151627(US8987445, 4)
Affinity DataIC50: 3.60nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151697(US8987445, 132)
Affinity DataIC50: 3.80nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151714(US8987445, 149)
Affinity DataIC50: 3.90nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151757(US8987445, 193)
Affinity DataIC50: 3.90nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151763(US8987445, 199)
Affinity DataIC50: 3.90nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151746(US8987445, 182)
Affinity DataIC50: 4nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151698(US8987445, 133)
Affinity DataIC50: 4.30nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151750(BDBM151751 | US8987445, 186)
Affinity DataIC50: 4.30nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151739(US8987445, 175)
Affinity DataIC50: 4.40nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151637(US8987445, 24)
Affinity DataIC50: 4.60nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151755(US8987445, 191)
Affinity DataIC50: 4.60nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151761(US8987445, 197)
Affinity DataIC50: 4.60nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151632(US8987445, 14)
Affinity DataIC50: 4.70nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151653(US8987445, 56)
Affinity DataIC50: 4.70nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151672(US8987445, 96)
Affinity DataIC50: 4.70nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151640(US8987445, 30)
Affinity DataIC50: 4.90nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

TargetTransient receptor potential cation channel subfamily M member 8(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM151633(US8987445, 17)
Affinity DataIC50: 5nMT: 2°CAssay Description:The functional activity of compounds was determined by measuring changes in intracellular calcium concentration using a Ca2+ sensitive fluorescent dy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
Go to US Patent

Displayed 1 to 50 (of 181 total ) | Next | Last >>
Jump to: